EUVIMEDEUVIMED entdecken
Crossref

Integrated bioinformatics and molecular docking ıdentify CCNB1, CDK1, and CYP1A2 as therapeutic targets of phytochemicals in hepatocellular carcinoma

Murat Isıyel, Hamid Ceylan, Yeliz Demir

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-02 · 399 (3) · 4129-4144

DOI: 10.1007/s00210-025-04729-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 16.10.2025. Verfasst von Murat Isıyel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Department of Molecular Biology and Genetics, Atatürk University, Erzurum, Türkiye. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CDC2 Protein Kinase, Cyclin B1. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a globally prevalent malignancy and a leading cause of cancer-related mortality; robust prognostic biomarkers and actionable therapeutic strategies are urgently needed. This study aimed to identify potential diagnostic and therapeutic gene targets in HCC through integrated transcriptomic and bioinformatics analyses. Specifically, we integrated four GEO microarray datasets to derive consensus differentially expressed genes (DEGs), constructed a high-confidence protein-protein interaction network, and prioritized hub genes using multiple CytoHubba topological metrics. To explore pharmacological relevance, hub genes were cross-referenced with known targets of four bioactive compounds (metformin, curcumin, resveratrol, silymarin) from the Comparative Toxicogenomics Database; in-silico validations (GEPIA2, UALCAN, TIMER) and molecular docking were then performed. We identified 290 consensus DEGs and seven hub genes, among which CCNB1 and CDK1 were upregulated while CYP1A2 was downregulated and selected as key candidates. Gene ontology and KEGG analyses implicated these genes in cell cycle progression and p53 signaling. Immune-infiltration analysis showed positive associations between CCNB1/CDK1 expression and innate immune cell infiltration, whereas CYP1A2 correlated negatively. Molecular docking revealed favorable binding affinities between the selected compounds and target proteins. Collectively, our results suggest CCNB1 and CDK1 as potential oncogenic markers and CYP1A2 as a putative tumor suppressor in HCC, warranting further functional validation for diagnostic and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCDC2 Protein KinaseCyclin B1Cytochrome P-450 CYP1A2PhytochemicalsAntineoplastic Agents, PhytogenicMolecular Docking SimulationHumansComputational BiologyProtein Interaction MapsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

BioinformaticsDEGsDockingHepatocellular carcinoma

Substanzen

CDC2 Protein KinaseCCNB1 protein, humanCyclin B1CDK1 protein, humanCytochrome P-450 CYP1A2PhytochemicalsAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Faculty of Science, Department of Molecular Biology and Genetics, Atatürk University, Erzurum, Türkiye.
  • Faculty of Science, Department of Molecular Biology and Genetics, Atatürk University, Erzurum, Türkiye. hamid.ceylan@atauni.edu.tr.
  • East Anatolian High Technology Research and Application Center (DAYTAM), Atatürk University, 25240, Erzurum, Türkiye. hamid.ceylan@atauni.edu.tr.
  • Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Türkiye. yelizdemir2116@gmail.com.
  • Faculty of Science, Department of Chemistry, Atatürk University, Erzurum, Türkiye. yelizdemir2116@gmail.com.

Zitieren

APA

Isıyel, M., Ceylan, H., & Demir, Y. (2026). Integrated bioinformatics and molecular docking ıdentify CCNB1, CDK1, and CYP1A2 as therapeutic targets of phytochemicals in hepatocellular carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(3), 4129-4144. https://doi.org/10.1007/s00210-025-04729-0

Vancouver

Isıyel M, Ceylan H, Demir Y. Integrated bioinformatics and molecular docking ıdentify CCNB1, CDK1, and CYP1A2 as therapeutic targets of phytochemicals in hepatocellular carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(3):4129-4144. doi:10.1007/s00210-025-04729-0

BibTeX
@article{Isyel2026,
  author = {Isıyel, Murat and Ceylan, Hamid and Demir, Yeliz},
  title = {Integrated bioinformatics and molecular docking ıdentify CCNB1, CDK1, and CYP1A2 as therapeutic targets of phytochemicals in hepatocellular carcinoma},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {3},
  pages = {4129--4144},
  doi = {10.1007/s00210-025-04729-0}
}
Kostenlos starten →